Thanks Jed :) Only published last December and results showed...

Thanks Jed
Only published last December and results showed BlastX was four times more effective than standard antibacterial treatment!!

…The treatment regimen included a 12-week daily application of a wound gel (experimental [BlastX; Next Science]) or a broad-spectrum antimicrobial ointment (control [Neosporin + Pain Relief; Johnson & Johnson]).
Patients ranged in age from 32 to 91 years (average age, 62 years).
Wound age ranged from 1 month to 20 years (average wound age, 21.2 months)…
…
… “The present analysis ….. demonstrates that using a biofilm-disrupting wound gel leads to superior reductions in bacterial load compared with traditional antimicrobials, with the product being 4 times more effective at reducing the bioburden from high to low levels.
These results are consistent with the improved wound size reduction found in the original study⁶ and indicate that the superior bacterial load reduction by the wound gel product leads to improved wound size reduction over time.”…

But the conclusion hardly shouts this from the rooftops.
— I guess that’s how they have to do things in ‘science speak’ ?

…Conclusion
The results of this study confirm that lower bacterial bioburden correlates with improved wound size reduction and closure.
These results also demonstrate that use of a biofilm-disrupting wound gel combined with debridement is more effective than the control antibiotic ointment combined with debridement in reducing the bacterial bioburden of wounds.
Wounds in the present study demonstrated measurable wound area reduction, increased wound closure rates, and a corresponding reduction in bioburden that reinforces the original research outcomes.”..

cheers

… As an afterthought, imagine how incredibly useful BlastX could if available to be used as a wound treatment for survivors in the aftermath of catastrophic events such as the Kahramanmaras earthquake. [BBC report ].
That it is not makes me incredibly furious with 3M which might have launched this benign and valuable product globally back in 2019, but instead bought distributor rights in order to throttle it :/